HDAC inhibitors: roles of DNA damage and repair.

Histone deacetylase inhibitors (HDACis) increase gene expression through induction of histone acetylation. However, it remains unclear whether specific gene expression changes determine the apoptotic response following HDACis administration. Herein, we discuss evidence that HDACis trigger in cancer and leukemia cells not only widespread histone acetylation but also actual increases in reactive oxygen species (ROS) and DNA damage that are further increased following treatment with DNA-damaging chemotherapies. While the origins of ROS production are not completely understood, mechanisms, including inflammation and altered antioxidant signaling, have been reported. While the generation of ROS is an explanation, at least in part, for the source of DNA damage observed with HDACi treatment, DNA damage can also be independently induced by changes in the DNA repair activity and chromatin remodeling factors. Recent development of sirtuin inhibitors (SIRTis) has shown that, similar to HDACis, these drugs induce increases in ROS and DNA damage used singly, or in combination with HDACis and other drugs. Thus, induction of apoptosis by HDACis/SIRTis may result through oxidative stress and DNA damage mechanisms in addition to direct activation of apoptosis-inducing genes. Nevertheless, while DNA damage and stress responses could be of interest as markers for clinical responses, they have yet to be validated as markers for responses to HDACi treatment in clinical trials, alone, and in combination.

[1]  P. Jeggo,et al.  The C Terminus of Ku80 Activates the DNA-Dependent Protein Kinase Catalytic Subunit , 1999, Molecular and Cellular Biology.

[2]  Stephen P. Jackson,et al.  Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair*S⃞ , 2009, Journal of Biological Chemistry.

[3]  H. Stunnenberg,et al.  Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008 , 2011, Molecular Cancer Therapeutics.

[4]  S. Guan,et al.  SIRT6 stabilizes DNA-dependent Protein Kinase at chromatin for DNA double-strand break repair , 2009, Aging.

[5]  Eleni P. Mimitou,et al.  Nucleases and helicases take center stage in homologous recombination. , 2009, Trends in biochemical sciences.

[6]  Tobias Rumpf,et al.  Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins). , 2010, Biochimica et biophysica acta.

[7]  S. Tucker,et al.  Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci , 2006, Molecular Cancer Therapeutics.

[8]  Cuk-Seong Kim,et al.  SIRT1 deacetylates APE1 and regulates cellular base excision repair , 2009, Nucleic acids research.

[9]  S. Kane,et al.  Regulation of WRN Protein Cellular Localization and Enzymatic Activities by SIRT1-mediated Deacetylation* , 2008, Journal of Biological Chemistry.

[10]  Huichen Wang,et al.  DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. , 2005, Cancer research.

[11]  M. Namdar,et al.  Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents , 2010, Proceedings of the National Academy of Sciences.

[12]  D. Wigley,et al.  CeBRC-2 stimulates D-loop formation by RAD-51 and promotes DNA single-strand annealing. , 2006, Journal of molecular biology.

[13]  Junjie Chen,et al.  SIRT1 Regulates Autoacetylation and Histone Acetyltransferase Activity of TIP60* , 2010, The Journal of Biological Chemistry.

[14]  J. Leith,et al.  Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB). , 1985, Radiation research.

[15]  Yingli Sun,et al.  DNA Damage-Induced Acetylation of Lysine 3016 of ATM Activates ATM Kinase Activity , 2007, Molecular and Cellular Biology.

[16]  M. Nussenzweig,et al.  A Backup DNA Repair Pathway Moves to the Forefront , 2007, Cell.

[17]  M. Krstic-Demonacos,et al.  Sirtuins: Molecular Traffic Lights in the Crossroad of Oxidative Stress, Chromatin Remodeling, and Transcription , 2011, Journal of biomedicine & biotechnology.

[18]  Bo Liu,et al.  Mitochondrial ROS generation for regulation of autophagic pathways in cancer. , 2011, Biochemical and biophysical research communications.

[19]  D. Longley,et al.  Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis , 2012, Cell Death and Differentiation.

[20]  I. Stamenkovic,et al.  Superoxide anion is a natural inhibitor of FAS‐mediated cell death. , 1996, The EMBO journal.

[21]  R. Medema,et al.  FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2SIRT1* , 2004, Journal of Biological Chemistry.

[22]  J. Walker,et al.  Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair , 2001, Nature.

[23]  I. Weissman,et al.  A PMLRARα transgene initiates murine acute promyelocytic leukemia , 1997 .

[24]  F. Vikhanskaya,et al.  Characterization of the 5’flanking Region of the Human chk1 Gene: Identification of E2F1 Functional Sites , 2003, Cell cycle.

[25]  J. Whetstine,et al.  Histone H3 methylation links DNA damage detection to activation of the Tip60 tumor suppressor , 2009, Nature Cell Biology.

[26]  X. Wang,et al.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. , 2008, Cancer cell.

[27]  Thioredoxin in cancer--role of histone deacetylase inhibitors. , 2006 .

[28]  J. Parvin,et al.  Histone Deacetylases 9 and 10 Are Required for Homologous Recombination* , 2011, The Journal of Biological Chemistry.

[29]  T. Lindahl,et al.  Quality control by DNA repair. , 1999, Science.

[30]  S. Jackson,et al.  Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation , 2010, Science.

[31]  Jiri Bartek,et al.  Human CtIP promotes DNA end resection , 2007, Nature.

[32]  G. Damonte,et al.  Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells , 2011, PloS one.

[33]  J. -. Park,et al.  TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL , 2010, Cell Death and Differentiation.

[34]  R. Bhatia,et al.  Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. , 2012, Blood.

[35]  M. Fraga,et al.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.

[36]  S. Elledge,et al.  The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.

[37]  W. Miller,et al.  Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells , 2011, PloS one.

[38]  S. Minucci,et al.  Histone deacetylases and epigenetic therapies of hematological malignancies. , 2010, Pharmacological research.

[39]  Lucia Altucci,et al.  Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.

[40]  Andrew J. Wilson,et al.  Hdac3 is essential for the maintenance of chromatin structure and genome stability. , 2010, Cancer cell.

[41]  L. Girard,et al.  Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide , 2011, British Journal of Cancer.

[42]  C. Chen,et al.  SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. , 2005, International journal of molecular medicine.

[43]  M. Wyatt,et al.  Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. , 2006, Chemical research in toxicology.

[44]  Delin Chen,et al.  Deacetylation of p53 modulates its effect on cell growth and apoptosis , 2000, Nature.

[45]  P. Atadja,et al.  The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide. , 2006, Molecular pharmacology.

[46]  Jorge A. Almenara,et al.  The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. , 2003, Cancer research.

[47]  P. Glazer,et al.  Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia , 2007, Oncogene.

[48]  R. Mantovani,et al.  DNA Damage Promotes Histone Deacetylase 4 Nuclear Localization and Repression of G2/M Promoters, via p53 C-terminal Lysines* , 2006, Journal of Biological Chemistry.

[49]  Ralph Scully,et al.  Role of mammalian Mre11 in classical and alternative non-homologous end joining , 2009, Nature Structural &Molecular Biology.

[50]  S. Pervaiz,et al.  Assessment of oxidative stress-induced DNA damage by immunoflourescent analysis of 8-oxodG. , 2011, Methods in cell biology.

[51]  M Raes,et al.  Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. , 1994, Free radical biology & medicine.

[52]  Claudia P. Miller,et al.  Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors , 2011, Journal of biomedicine & biotechnology.

[53]  T. Okamoto,et al.  Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. , 1993, The Journal of biological chemistry.

[54]  C. Bradbury,et al.  Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors , 2005, Leukemia.

[55]  M. Hedayati,et al.  Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor , 2010, PloS one.

[56]  D. Ferguson,et al.  Multiple functions of MRN in end-joining pathways during isotype class switching , 2009, Nature Structural &Molecular Biology.

[57]  S. Jackson,et al.  The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.

[58]  Steven S. Foster,et al.  Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair , 2010, Proceedings of the National Academy of Sciences.

[59]  W. Plunkett,et al.  Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal. , 2006, Blood.

[60]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[61]  S. Baylin,et al.  Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island , 2008, PLoS genetics.

[62]  George Iliakis,et al.  PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways , 2006, Nucleic acids research.

[63]  Pingfang Liu,et al.  Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2006, Cell.

[64]  É. Ogier-Denis,et al.  Les Nox/Duox : une nouvelle famille de NADPH oxydases , 2006 .

[65]  P. Marks,et al.  Histone deacetylase inhibitors: molecular mechanisms of action , 2007, Oncogene.

[66]  R. Taneja,et al.  Oxidative stress regulation of stem and progenitor cells. , 2009, Antioxidants & redox signaling.

[67]  L. Magnaghi-Jaulin,et al.  Histone deacetylase inhibitors and genomic instability. , 2009, Cancer letters.

[68]  William Arbuthnot Sir Lane,et al.  SIRT1 regulates the function of the Nijmegen breakage syndrome protein. , 2007, Molecular cell.

[69]  S. Iida,et al.  Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells , 2007, Leukemia.

[70]  S. Jackson,et al.  Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4 , 2010, The EMBO journal.

[71]  Ralph Scully,et al.  Mechanisms of double-strand break repair in somatic mammalian cells. , 2009, The Biochemical journal.

[72]  L. Gordon,et al.  PCI-24781 Induces Caspase and Reactive Oxygen Species–Dependent Apoptosis Through NF-κB Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells , 2009, Clinical Cancer Research.

[73]  G. Mufti,et al.  Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis? , 2006, Molecular Cancer Research.

[74]  S. Miyamoto Nuclear initiated NF-κB signaling: NEMO and ATM take center stage , 2011, Cell Research.

[75]  Xiaofeng Jiang,et al.  The FATC Domains of PIKK Proteins Are Functionally Equivalent and Participate in the Tip60-dependent Activation of DNA-PKcs and ATM* , 2006, Journal of Biological Chemistry.

[76]  P. Jeggo,et al.  The two edges of the ATM sword: co-operation between repair and checkpoint functions. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[77]  L. Altucci,et al.  Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells , 2005, Nature Medicine.

[78]  M. Guenther,et al.  Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response , 2003, The Journal of cell biology.

[79]  Penny A. Jeggo,et al.  The role of double-strand break repair — insights from human genetics , 2006, Nature Reviews Genetics.

[80]  P. Dent,et al.  Kinase 1 Activation Downregulation, and C-jun N-terminal Mediated by Oxidative Damage, Xiap Leukemia Cells through a Process B Activation Potentiates Apoptosis in Κ Nf- Inhibitor-induced Rela/p65 Acetylation and Blockade of Histone Deacetylase , 2005 .

[81]  E. Seto,et al.  Lysine acetylation: codified crosstalk with other posttranslational modifications. , 2008, Molecular cell.

[82]  C. Deng,et al.  SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. , 2010, Cancer cell.

[83]  C. Benz,et al.  Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes , 2005, Clinical Cancer Research.

[84]  I. Christensen,et al.  Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas , 2009, Histopathology.

[85]  R. Salgia,et al.  Hematopoietic growth factors signal through the formation of reactive oxygen species. , 1999, Blood.

[86]  Xiaofeng Jiang,et al.  Tip60: Connecting chromatin to DNA damage signaling , 2010, Cell cycle.

[87]  J. Jiricny,et al.  Recent progress in the biology, chemistry and structural biology of DNA glycosylases , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[88]  J. Nam,et al.  Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues. , 2008, Journal of gynecologic oncology.

[89]  G. Perez,et al.  Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Lübbert,et al.  Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy , 2010, Clinical Epigenetics.

[91]  David J. Chen,et al.  The DNA-dependent Protein Kinase Catalytic Activity Regulates DNA End Processing by Means of Ku Entry into DNA* , 1999, The Journal of Biological Chemistry.

[92]  D. Roth,et al.  Mechanisms of nonhomologous recombination in mammalian cells , 1985, Molecular and cellular biology.

[93]  J. McCaul,et al.  Sirtuins, Bioageing, and Cancer , 2011, Journal of aging research.

[94]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[95]  G. Perez,et al.  Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor , 2006, Proceedings of the National Academy of Sciences.

[96]  D. Roth,et al.  Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. , 2009, Molecular cell.

[97]  P. Calsou,et al.  Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway. , 2008, Biochemical and biophysical research communications.

[98]  David J. Chen,et al.  MOF and Histone H4 Acetylation at Lysine 16 Are Critical for DNA Damage Response and Double-Strand Break Repair , 2010, Molecular and Cellular Biology.

[99]  J A Hardin,et al.  Mechanism of interaction between Ku protein and DNA. , 1986, The Journal of biological chemistry.

[100]  J. Bartek,et al.  More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance , 2011, Nature Cell Biology.

[101]  Ke Gong,et al.  CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells. , 2012, The Biochemical journal.

[102]  M. Esteller,et al.  Epigenetic control of nuclear architecture , 2007, Cellular and Molecular Life Sciences.

[103]  Hiroko Yamashita,et al.  Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast* , 2005, Breast Cancer Research and Treatment.

[104]  T. Misteli,et al.  The emerging role of nuclear architecture in DNA repair and genome maintenance , 2009, Nature Reviews Molecular Cell Biology.

[105]  S. Tucker,et al.  Histone Deacetylase Inhibitors Radiosensitize Human Melanoma Cells by Suppressing DNA Repair Activity , 2005, Clinical Cancer Research.

[106]  A. Tomkinson,et al.  Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. , 2008, Blood.

[107]  P. Fisher,et al.  Histone Deacetylase Inhibitors Activate NF-κB in Human Leukemia Cells through an ATM/NEMO-related Pathway* , 2010, The Journal of Biological Chemistry.

[108]  T. Suda,et al.  Regulation of reactive oxygen species in stem cells and cancer stem cells , 2012, Journal of cellular physiology.

[109]  S. Park,et al.  Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. , 2010, Molecular cell.

[110]  K. Caldecott Mammalian single-strand break repair: mechanisms and links with chromatin. , 2007, DNA repair.

[111]  D. Cortez,et al.  Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. , 2008, Molecular cell.

[112]  J. Jassem,et al.  Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer , 2011, Drugs.

[113]  Jean Gautier,et al.  Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells , 2009, Nature Structural &Molecular Biology.

[114]  Yoshiharu Kawaguchi,et al.  MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation , 2002, The EMBO journal.

[115]  J. Lamerdin,et al.  XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. , 1998, Molecular cell.

[116]  Xiaoling Li,et al.  Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C , 2010, Proceedings of the National Academy of Sciences.

[117]  N. Nalabothula,et al.  Cancer cells' epigenetic composition and predisposition to histone deacetylase inhibitor sensitization. , 2011, Epigenomics.

[118]  Martin Kühne,et al.  A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. , 2004, Molecular cell.

[119]  D. Reinberg,et al.  SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. , 2007, Genes & development.

[120]  M. Grever,et al.  Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. , 2006, Cancer research.

[121]  S. Payne,et al.  Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. , 2005, Cancer research.

[122]  G. Park,et al.  SIRT1 promotes DNA repair activity and deacetylation of Ku70 , 2007, Experimental & Molecular Medicine.

[123]  Nita Ahuja,et al.  Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. , 2012, Cancer cell.

[124]  A. Imbalzano,et al.  Mammalian SWI/SNF complexes facilitate DNA double‐strand break repair by promoting γ‐H2AX induction , 2006, The EMBO journal.

[125]  S. Grant,et al.  The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. , 2004, International journal of oncology.

[126]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[127]  Peter Gwynne,et al.  Drug Discovery: 5 , 2002 .

[128]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[129]  J. Friedberg,et al.  Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo , 2011, Molecular Cancer Therapeutics.

[130]  L. Samson,et al.  Base excision repair in yeast and mammals. , 2000, Mutation research.

[131]  J. Yokota,et al.  Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors , 2011, Oncogene.

[132]  V. Bohr,et al.  Base excision repair of oxidative DNA damage and association with cancer and aging. , 2008, Carcinogenesis.

[133]  G. Marshall,et al.  The critical role of the class III histone deacetylase SIRT1 in cancer. , 2009, Cancer research.

[134]  L. Altucci,et al.  ERRATUM: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.

[135]  P. Marks,et al.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.

[136]  S. Jackson,et al.  Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining , 2010, Nature Structural &Molecular Biology.

[137]  I. Rahman,et al.  Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. , 2004, Biochemical pharmacology.

[138]  M. Mann,et al.  Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.

[139]  M. Falzon,et al.  EBP-80, a transcription factor closely resembling the human autoantigen Ku, recognizes single- to double-strand transitions in DNA. , 1993, The Journal of biological chemistry.

[140]  Arunasree M. Kalle,et al.  Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells. , 2010, Biochemical and biophysical research communications.

[141]  Myriam Gorospe,et al.  Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase , 2004, Science.

[142]  Xiaodan Yu,et al.  Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells. , 2008, Journal of proteome research.

[143]  A. Seluanov,et al.  SIRT6 Promotes DNA Repair Under Stress by Activating PARP1 , 2011, Science.

[144]  K. Camphausen,et al.  Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275 , 2004, Cancer Research.

[145]  M. Kelley,et al.  Review of mammalian DNA repair and translational implications. , 2000, The Journal of pharmacology and experimental therapeutics.

[146]  Jessica E. Bolden,et al.  Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.

[147]  S. Pervaiz,et al.  Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells , 2012, Cell Death and Differentiation.

[148]  Jorge A. Almenara,et al.  Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions , 2008, Molecular Cancer Therapeutics.

[149]  T. Kundu,et al.  Reversible acetylation of chromatin: Implication in regulation of gene expression, disease and therapeutics , 2009, Biotechnology journal.

[150]  Jianyuan Luo,et al.  SIRT1 regulates UV-induced DNA repair through deacetylating XPA. , 2010, Molecular cell.

[151]  Z. Herceg,et al.  Histone acetylation by Trrap–Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks , 2006, Nature Cell Biology.

[152]  A. Sancar,et al.  Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.

[153]  S. Grant,et al.  HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo , 2011, Clinical Cancer Research.

[154]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.

[155]  Paul Van Houtte,et al.  NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. , 2006, Cancer letters.

[156]  William Arbuthnot Sir Lane,et al.  SIRT1 Deacetylates the DNA Methyltransferase 1 (DNMT1) Protein and Alters Its Activities , 2011, Molecular and Cellular Biology.

[157]  Yung-Hyun Choi,et al.  Sensing of Ionizing Radiation-induced DNA Damage by ATM through Interaction with Histone Deacetylase* , 1999, The Journal of Biological Chemistry.

[158]  M. V. Van Dyke,et al.  Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated. , 2007, Chemistry & biology.

[159]  O. Hermanson,et al.  Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide , 2010, Oncogene.

[160]  K. Khanna,et al.  DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.

[161]  Y. Yamaoka,et al.  Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. , 1994, Immunology letters.

[162]  Ricky W. Johnstone,et al.  Histone-deacetylase inhibitors: novel drugs for the treatment of cancer , 2002, Nature Reviews Drug Discovery.

[163]  Andrew W Truman,et al.  Epigenetic Modifications in Double-Strand Break DNA Damage Signaling and Repair , 2010, Clinical Cancer Research.

[164]  R. Kreienberg,et al.  Role of SIRT1 in homologous recombination. , 2010, DNA repair.

[165]  W. Weichert,et al.  Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy , 2008, British Journal of Cancer.

[166]  K. Anderson,et al.  Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells , 2011, British journal of haematology.

[167]  Y. Oda,et al.  Expression profile of class I histone deacetylases in human cancer tissues. , 2007, Oncology reports.

[168]  P. Dhar,et al.  Collaborative roles of gammaH2AX and the Rad51 paralog Xrcc3 in homologous recombinational repair. , 2007, DNA repair.

[169]  Stephen P. Jackson,et al.  Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage , 2005, Nature.

[170]  G. Kristiansen,et al.  Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma , 2010, Expert opinion on therapeutic targets.

[171]  Francis J Giles,et al.  Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. , 2008, Cancer letters.

[172]  D. Bernhard,et al.  The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[173]  Ching-Yu Chen,et al.  Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. , 2007, Cancer research.

[174]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[175]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[176]  C. Simone,et al.  Physical and Functional HAT/HDAC Interplay Regulates Protein Acetylation Balance , 2010, Journal of biomedicine & biotechnology.

[177]  Markus Löbrich,et al.  ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2 , 2009, The EMBO journal.

[178]  N. L. La Thangue,et al.  HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications , 2012, Immunology and cell biology.

[179]  A. El-Osta,et al.  The Epigenetic Modifier, Valproic Acid, Enhances Radiation Sensitivity , 2006, Epigenetics.

[180]  Hidde Ploegh,et al.  Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. , 2004, Molecular cell.

[181]  George Iliakis,et al.  Backup pathways of NHEJ in cells of higher eukaryotes: cell cycle dependence. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[182]  L. Altucci,et al.  Sirtuins and Disease: The Road Ahead , 2012, Front. Pharmacol..

[183]  H. Scher,et al.  The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[184]  D. Roth,et al.  Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction , 1986, Molecular and cellular biology.

[185]  Peng Huang,et al.  Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event , 2004, Cancer Chemotherapy and Pharmacology.

[186]  Xiaofeng Jiang,et al.  A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. , 2005, Proceedings of the National Academy of Sciences of the United States of America.